American Journal of Clinical Dermatology

, Volume 4, Issue 6, pp 371–378 | Cite as

Skin Aging and Menopause

Implications for Treatment
  • Nicholas J. Raine-Fenning
  • Mark P. Brincat
  • Yves Muscat-Baron
Current Opinion


The skin is one of the largest organs of the body, which is significantly affected by the aging process and menopause. The significant changes sustained by the skin during the menopause are due to the effect sustained on the skin’s individual components.

The estrogen receptor has been detected on the cellular components of the skin. Accordingly, dermal cellular metabolism is influenced by the hypoestrogenoemic state of menopause leading to changes in the collagen content, alterations in the concentration of glycoaminoglycans and most importantly the water content. Consequently changes in these basic components leads to an alteration in function compatible with skin aging.

Changes in the skin collagen leads to diminished elasticity and skin strength. Collagen content may be measured by various methods such as direct skin biopsy, skin blister assessment for collagen markers and skin thickness measurement. All these variables indicate a reduction in collagen content following menopause. This may be reversed with the administration of estrogen given both topically and systemically.

A reduction in hydrophilic glycoaminglycans leads to a direct reduction in water content, which influences the skin turgor. These effects on glycoaminoglycans, due to the hypoestrogenia, have been clearly shown in animal studies and appeared to be rapidly reversed with the application of estrogens. The sum total of these basic effects on the skin leads to wrinkles, the skin condition typifying skin aging.

Structures resident in the skin are likewise influenced by menopause. Changes to the cutaneous vascular reactivity are noted following menopause. Capillary blood flow velocity decreases significantly in postmenopausal women. Postmenopausal flushing is due to profound vasodilatation in the dermal papillae. Hair growth is also influenced by the hormonal milieu and consequently hair loss has been associated with the beginning of menopause.

Treatments administered for menopause, in particular hormone replacement therapy, appear to alter its effects on the basic components of the skin as well as the more complex structures residing in the skin, consequently retarding the skin aging process.


  1. 1.
    Raine-Fenning NJ, Sant RA, Brincat MP. HRT in the new millennium. Contemp Clin Gynecol & Obstets 2001; 1 (1): 7–23Google Scholar
  2. 2.
    Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol 2001; 45: S116–S124PubMedCrossRefGoogle Scholar
  3. 3.
    Punnonen R, Lovgren T, Kouvonen I. Demonstration of estrogen receptors in the skin. J Endocrinol Invest 1980; 3 (3): 217–221Google Scholar
  4. 4.
    Alberts B, Bray D, Lewis J, et al. Molecular biology of the Cell. 3rd ed. New York: Garland Publishing Inc, 1994Google Scholar
  5. 5.
    Jemec GB, Bhogal BS, Wojnarowska F. Are acquired nevi oestrogen-dependent tumours? Acta Derm Venereol 1987; 67 (5): 451–453PubMedGoogle Scholar
  6. 6.
    Jemec GB, Wojnarowska F. The distribution of p29 protein in normal human skin. Br J Dermatol 1987; 117 (2): 217–224PubMedCrossRefGoogle Scholar
  7. 7.
    MacLean AB, Nicol LA, Hodgins MB. Immunohistochemical localization of estrogen receptors in the vulva and vagina. J Reprod Med 1990; 35 (11): 1015–1016PubMedGoogle Scholar
  8. 8.
    Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990; 30 (2): 97–100PubMedCrossRefGoogle Scholar
  9. 9.
    Albright F, Bloomberg E, Smith PH. Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940; 55: 298–305Google Scholar
  10. 10.
    McConkey B, Fraser GR, Bligh AS, et al. Transparent skin and osteoporosis. Lancet 1963; I: 693–695CrossRefGoogle Scholar
  11. 11.
    Brincat M, Moniz CJ, Studd JW, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985; 92 (3): 256–259PubMedCrossRefGoogle Scholar
  12. 12.
    Rauramo L, Punnonen R. Effect of oral estrogen treatment with estriol succinate on the skin of castrated women. Z Haut Geschlechtskr 1969; 44 (13): 463–470PubMedGoogle Scholar
  13. 13.
    Punnonen R. On the effect of castration and peroral estrogen therapy on the skin. Acta Obstet Gynecol Scand 1971; 9 Suppl. 9: 32Google Scholar
  14. 14.
    Pierard-Franchimont C, Cornil F, Dehavey J, et al. Climacteric skin ageing of the face: a prospective longitudinal comparative trail on the effect of oral hormone replacement therapy. Maturitas 1999; 32: 87–93PubMedCrossRefGoogle Scholar
  15. 15.
    Tan CY, Statham B, Marks R, et al. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol 1982; 106 (6): 657–667PubMedGoogle Scholar
  16. 16.
    Haapasaari KM, Raudaskoski T, Kallioinen M, et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas 1997; 27: 153–162PubMedCrossRefGoogle Scholar
  17. 17.
    Chen L, Dyson M, Rymer J, et al. The use of high frequency diagnostic ultrasound to investigate the effect of hormone replacement therapy on skin thickness. Skin Res Technol 2001; 7: 95–97PubMedCrossRefGoogle Scholar
  18. 18.
    Maheux R, Naud F, Rioux M, et al. A randomized, double-blind, placebocontrolled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 1994; 170 (2): 642–649PubMedGoogle Scholar
  19. 19.
    Black MM, Bottoms E, Shuster S. Skin collagen content and thickness in systemic sclerosis. Br J Dermatol 1970; 83 (5): 552–555PubMedCrossRefGoogle Scholar
  20. 20.
    Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975; 93 (6): 639–643PubMedCrossRefGoogle Scholar
  21. 21.
    Brincat M, Moniz CF, Studd JW, et al. Sex hormones and skin collagen content in postmenopausal women. Br Med J (Clin Res Ed) 1983; 287 (6402): 1337–1338CrossRefGoogle Scholar
  22. 22.
    Sauerbronn A VD, Fonseca AM, Bagnoli VR, et al. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000; 68: 35–41PubMedCrossRefGoogle Scholar
  23. 23.
    Oikarinen A. Systemic estrogens have no conclusive beneficial effect on human skin connective tissur. Acta Obstet Gynaecol Scand 2000; 79: 250–254CrossRefGoogle Scholar
  24. 24.
    Savvas M, Bishop J, Laurent G, et al. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br J Obstet Gynaecol 1993; 100 (2): 154–156PubMedCrossRefGoogle Scholar
  25. 25.
    Brincat M, Versi E, O’Dowd T, et al. Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas 1987; 9 (1): 1–5PubMedCrossRefGoogle Scholar
  26. 26.
    Shahrad P, Marks R. A pharmacological effect of oestrone on human epidermis. Br J Dermatol 1977; 97 (4): 383–386CrossRefGoogle Scholar
  27. 27.
    Holland EF, Studd JW, Mansell JP, et al. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet Gynecol 1994; 83 (2): 180–183PubMedGoogle Scholar
  28. 28.
    Brincat M, Moniz CF, Kabalan S, et al. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynaecol 1987; 94 (2): 126–129PubMedCrossRefGoogle Scholar
  29. 29.
    Varila E, Rantala I, Oikarinen A, et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 1995; 102 (12): 985–989PubMedCrossRefGoogle Scholar
  30. 30.
    Black MM, Shuster S, Bottoms E. Osteoporosis, skin collagen, and androgen. BMJ 1970; 4 (738): 773–774PubMedCrossRefGoogle Scholar
  31. 31.
    Shuster S, Black MM, Bottoms E. Skin collagen and thickness in women with hirsuties. BMJ 1970; 4 (738): 772PubMedCrossRefGoogle Scholar
  32. 32.
    Hall DA, Reed FB, Nuki G, et al. The relative effects of age and corticosteroid therapy on the collagen profiles of dermis from subjects with rheumatoid arthritis. Age Ageing 1974; 3 (1): 15–22PubMedCrossRefGoogle Scholar
  33. 33.
    Danforth DN, Veis A, Breen M, et al. The effect of pregnancy and labor on the human cervix: changes in collagen, glycoproteins, and glycosaminoglycans. Am J Obstet Gynecol 1974; 120 (5): 641–651PubMedGoogle Scholar
  34. 34.
    Grosman N, Hvidberg E, Schou J. The effect of oestrogenic treatment on the acid mucopolysaccharide pattern in skin of mice. Acta Pharmacol Toxicol 1971; 30 (5): 458–464CrossRefGoogle Scholar
  35. 35.
    Lim SC, Caballero AE, Arora S, et al. The effect of hormonal replacement therapy on the vascular reactivity and ebdothelial function of healthy individuals and individuals with type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 4159–4164PubMedCrossRefGoogle Scholar
  36. 36.
    Arora S, Veves A, Caballaro AE, et al. Estrogen improves endothelial function. J Vasc Surg 1998; 27 (6): 1141–1146PubMedCrossRefGoogle Scholar
  37. 37.
    Harvell J, Hussona-Saeed I, Maibach HI. Changes in transepidermal water loss and cutaneous blood flow during the menstrual cycle. Contact Dermatitis 1992; 27 (5): 294–301PubMedCrossRefGoogle Scholar
  38. 38.
    Haenggi W, Linder HR, Birkhaeuser MH, et al. Microscopic findings of the nail-fold capillaries: dependence on menopausal status and hormone replacement therapy. Maturitas 1995; 22 (1): 37–46PubMedCrossRefGoogle Scholar
  39. 39.
    Brooks EM, Morgan AL, Pierzga JM, et al. Chronic hormone replacement therapy alters thermoregulatory and vasomotor function in postmenopausal women. J Appl Physiol 1997; 83 (2): 477–484PubMedGoogle Scholar
  40. 40.
    Ginsburg J, Hardiman P, O’Reilly B. Peripheral blood flow in menopausal women who have hot flushes and in those who do not. BMJ 1989; 298 (6686): 1488–1490PubMedCrossRefGoogle Scholar
  41. 41.
    Brincat M, de Trafford JC, Lafferty K, et al. Peripheral vasomotor control and menopausal flushing: a preliminary report. Br J Obstet Gynaecol 1984; 91 (11): 1107–1110PubMedCrossRefGoogle Scholar
  42. 42.
    Brincat M, Kabalan S, Studd JW, et al. A study of the decrease of skin collagen content, skin thickness and bone mass in the postmenopausal woman. Obstet Gynaecol 1987; 70: 840–845Google Scholar
  43. 43.
    Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999; 33: 239–247PubMedCrossRefGoogle Scholar
  44. 44.
    Shah MG, Maibach HI. Estrogen and skin: an overview. Am J Clin Dermatol 2001; 2: 143–150PubMedCrossRefGoogle Scholar
  45. 45.
    Varila E, Sievanen H, Vuori I, et al. Limited value of ultrasound measured skin thickness in predicting bone mineral density in peri- and postmenopausal women. Maturitas 1995; 21 (1): 45–49PubMedCrossRefGoogle Scholar
  46. 46.
    Shelley WB, Shelley ED, Talanin NY, et al. Estrogen dermatitis. J Am Acad Dermatol 1995; 32 (1): 25–31PubMedCrossRefGoogle Scholar
  47. 47.
    Leylek OA, Unlu S, Ozturkcan S, et al. Estrogen dermatitis. Eur J Obstet Gynecol Reprod Biol 1997; 72 (1): 97–103PubMedCrossRefGoogle Scholar
  48. 48.
    Kim KH, Yoon TJ, Oh CW, et al. A case of estrogen dermatitis. J Dermatol 1997; 24 (5): 332–336PubMedGoogle Scholar
  49. 49.
    Paquet F, Pierard-Franchimont C, Fumal I, et al. Sensitive skin at menopause; dew point and electrometric properties of the stratum corneum. Maturitas 1998; 28 (3): 221–227PubMedCrossRefGoogle Scholar
  50. 50.
    O’Neill S, Kirkegard Y. An Australian experience of transdermal oestradiol patches in a subtropical climate. Aust N Z J Obstet Gynaecol 1993; 33 (3): 327–329PubMedCrossRefGoogle Scholar
  51. 51.
    McCarthy T, Dramrusic V, Ratnam S. Use of two types of estradiol-releasing skin patches for menopausal patients in a tropical climate. Am J Obstet Gynecol 1992; 166 (6 Pt 2): 2005–2010PubMedGoogle Scholar
  52. 52.
    Corson SL. Clinical experience with Systen, a new transdermal form of hormone replacement therapy. Int J Fertil Menopausal Stud 1993; 38 Suppl. 1: 36–44PubMedGoogle Scholar
  53. 53.
    Wallace ML, Smoller BR. Estrogen and progesterone receptors in androgenic alopecia versus alopecia areata. Am J Dermatopathol 1998; 20 (2): 160–163PubMedCrossRefGoogle Scholar
  54. 54.
    Oh HS, Smart RC. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA 1996; 93 (22): 12525–12530PubMedCrossRefGoogle Scholar
  55. 55.
    Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol 1997; 36 (1): 59–66PubMedCrossRefGoogle Scholar
  56. 56.
    Schmidt JB, Binder M, Macheiner W, et al. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds: a pilot study. Maturitas 1994; 20 (1): 25–30PubMedCrossRefGoogle Scholar
  57. 57.
    Anttinen H, Orava S, Ryhanen L, et al. Assay of protocollagen lysyl hydroxylase activity in the skin of human subjects and changes in the activity with age. Clin Chim Acta 1973; 47 (2): 289–294PubMedCrossRefGoogle Scholar
  58. 58.
    Henry F, Pierard-Franchimont C, Cauwenbergh G, et al. Age-related changes in facial skin contours and rheology. J Am Geriatr Soc 1997; 45 (2): 220–222PubMedGoogle Scholar
  59. 59.
    Dunn LB, Damesyn M, Moore AA, et al. Does estrogen prevent skin aging? Results from the First National Health and Nutrition Examination Survey (NHANES I). Arch Dermatol 1997; 133 (3): 339–342PubMedCrossRefGoogle Scholar
  60. 60.
    Pierard GE, Letawe C, Dowlati A, et al. Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995; 43 (6): 662–665PubMedGoogle Scholar
  61. 61.
    Sator PG, Schmidt JB, Sator MO, et al. The influence of hormone replacement therapy on skin ageing: a pilot study Maturitas 2001; 39: 43–55Google Scholar
  62. 62.
    Castelo-Branco C, Figueras F, Martinez de Osaba MJ, et al. Facial wrinkling in postmenopausal women: effects of smoking status and hormone replacement therapy. Maturitas 1998; 29 (1): 75–86PubMedCrossRefGoogle Scholar
  63. 63.
    Ramamrurthy NS, McClain SA, Pirila E, et al. Wound healing in aged normal and ovariectomised rats: effects of chemically modified doxycycline (CMT-8) on MMP expression and collagen synthesis. Ann NY Acad Sci 1999; 878: 720–723Google Scholar
  64. 64.
    Pirila E, Ramamrurthy N, Maisi P, et al. Wound healing in ovariectomised rats: effects of chemically modified tetracyclinr (VMT -8) and estrogen on matrix metalloproteinases-8, -13 and type I collagen expression. Curr Med Chem 2001; 8: 281–294PubMedCrossRefGoogle Scholar
  65. 65.
    Ashcroft GS, Greenwelk-Wild T, Horan MA, et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999; 155: 1137–1146Google Scholar
  66. 66.
    Ashcroft GS, Dodsworth J, van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-betal levels. Nat Med 1997; 3 (11): 1209–1215PubMedCrossRefGoogle Scholar
  67. 67.
    Schmidt JB, Binder M, Macheiner W, et al. New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin. Int J Dermatol 1995; 34 (1): 53–57PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Authors and Affiliations

  • Nicholas J. Raine-Fenning
    • 1
  • Mark P. Brincat
    • 2
  • Yves Muscat-Baron
    • 2
  1. 1.Academic Division of Reproductive MedicineUniversity of NottinghamNottinghamUK
  2. 2.Department of Obstetrics and GynaecologyFaculty of Medicine and Surgery, University of MaltaMsidaMalta

Personalised recommendations